|
1
|
Esposito L, Conti D, Ailavajhala R, Khalil
N and Giordano A: Lung cancer: are we up to the challenge? Curr
Genomics. 11:513–518. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar
|
|
4
|
Hermann PC, Bhaskar S, Cioffi M and
Heeschen C: Cancer stem cells in solid tumors. Semin Cancer Biol.
20:77–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clevers H: The cancer stem cell: premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sneddon JB and Werb Z: Location, location,
location: the cancer stem cell niche. Cell Stem Cell. 1:607–611.
2007. View Article : Google Scholar
|
|
7
|
Zhang WC, Shyh-Chang N, Yang H, Rai A,
Umashankar S, Ma S, Soh BS, Sun LL, Tai BC, Nga ME, et al: Glycine
decarboxylase activity drives non-small cell lung cancer
tumor-initiating cells and tumorigenesis. Cell. 148:259–272. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen YC, Hsu HS, Chen YW, Tsai TH, How CK,
Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong
CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu C, Xie D, Yu SC, Yang XJ, He LR, Yang
J, Ping YF, Wang B, Yang L, Xu SL, et al: β-catenin/POU5F1/SOX2
transcription factor complex mediates IGF-I receptor signaling and
predicts poor prognosis in lung adenocarcinoma. Cancer Res.
73:3181–3189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anthony EL, King JC and Stopa EG:
Immunocytochemical localization of LHRH in the median eminence,
infundibular stalk, and neurohypophysis. Evidence for multiple
sites of releasing hormone secretion in humans and other mammals.
Cell Tissue Res. 236:5–14. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stopa EG, Koh ET, Svendsen CN, Rogers WT,
Schwaber JS and King JC: Computer-assisted mapping of
immunoreactive mammalian gonadotropin-releasing hormone in adult
human basal forebrain and amygdala. Endocrinology. 128:3199–3207.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Conn PM and Crowley WF Jr:
Gonadotropin-releasing hormone and its analogs. Annu Rev Med.
45:391–405. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Montagnani Marelli M, Moretti RM,
Januszkiewicz-Caulier J, Motta M and Limonta P:
Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new
rationale for the therapeutical application of GnRH analogs in
cancer patients? Curr Cancer Drug Targets. 6:257–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheung LW and Wong AS:
Gonadotropin-releasing hormone: GnRH receptor signaling in
extrapituitary tissues. FEBS J. 275:5479–5495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
So WK, Cheng JC, Poon SL and Leung PC:
Gonadotropin-releasing hormone and ovarian cancer: a functional and
mechanistic overview. FEBS J. 275:5496–5511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gründker C, Schlotawa L, Viereck V and
Emons G: Protein kinase C-independent stimulation of activator
protein-1 and c-Jun N-terminal kinase activity in human endometrial
cancer cells by the LHRH agonist triptorelin. Eur J Endocrinol.
145:651–658. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Limonta P, Moretti RM, Marelli MM, Dondi
D, Parenti M and Motta M: The luteinizing hormone-releasing hormone
receptor in human prostate cancer cells: messenger ribonucleic acid
expression, molecular size, and signal transduction pathway.
Endocrinology. 140:5250–5256. 1999.PubMed/NCBI
|
|
19
|
Kim IG, Kim SY, Choi SI, Lee JH, Kim KC
and Cho EW: Fibulin-3-mediated inhibition of
epithelial-to-mesenchymal transition and self-renewal of ALDH lung
cancer stem cells through IGF1R signaling. Oncogene. 1:1–10.
2013.
|
|
20
|
Mo XM, Li HH, Liu M and Li YT:
Downregulation of GSK3β by miR-544a to maintain self-renewal
ability of lung cancer stem cells. Oncol Lett. 8:1731–1734.
2014.PubMed/NCBI
|
|
21
|
Liu F, Cao X, Liu Z, Guo H, Ren K, Quan M,
Zhou Y, Xiang H and Cao J: Casticin suppresses self-renewal and
invasion of lung cancer stem-like cells from A549 cells through
down-regulation of pAkt. Acta Biochim Biophys Sin (Shanghai).
46:15–21. 2014. View Article : Google Scholar
|
|
22
|
Metallinou C, Köster F, Diedrich K,
Nikolettos N and Asimakopoulos B: The effects of cetrorelix and
triptorelin on the viability and steroidogenesis of cultured human
granulosa luteinized cells. In Vivo. 26:835–839. 2012.PubMed/NCBI
|
|
23
|
Kraus S, Levy G, Hanoch T, Naor Z and
Seger R: Gonadotropin-releasing hormone induces apoptosis of
prostate cancer cells: role of c-Jun NH2-terminal kinase, protein
kinase B, and extracellular signal-regulated kinase pathways.
Cancer Res. 64:5736–5744. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheung LW, Leung PC and Wong AS:
Gonadotropin-releasing hormone promotes ovarian cancer cell
invasiveness through c-Jun NH2-terminal kinase-mediated activation
of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res.
66:10902–10910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huntly BJ and Gilliland DG: Cancer
biology: summing up cancer stem cells. Nature. 435:1169–1170. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sueblinvong V and Weiss DJ: Stem cells and
cell therapy approaches in lung biology and diseases. Transl Res.
156:188–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Limonta P, Moretti RM, Montagnani Marelli
M and Motta M: The biology of gonadotropin hormone-releasing
hormone: role in the control of tumor growth and progression in
humans. Front Neuroendocrinol. 24:279–295. 2003. View Article : Google Scholar
|
|
29
|
Harrison GS, Wierman ME, Nett TM and Glode
LM: Gonadotropin-releasing hormone and its receptor in normal and
malignant cells. Endocr Relat Cancer. 11:725–748. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chou CS, Tai CJ, MacCalman CD and Leung
PC: Dose-dependent effects of gonadotropin releasing hormone on
matrix metalloproteinase (MMP)-2, and MMP-9 and tissue specifc
inhibitor of metalloproteinases-1 messenger ribonucleic acid levels
in human decidual stromal cells in vitro. J Clin Endocrinol Metab.
88:680–688. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moretti RM, Montagnani Marelli M, Mai S
and Limonta P: Gonadotropin-releasing hormone agonists suppress
melanoma cell motility and invasiveness through the inhibition of
α3 integrin and MMP-2 expression and activity. Int J Oncol.
33:405–413. 2008.PubMed/NCBI
|
|
32
|
Dondi D, Limonta P, Moretti RM, Marelli
MM, Garattini E and Motta M: Antiproliferative effects of
luteinizing hormone-releasing hormone (LHRH) agonists on human
androgen-independent prostate cancer cell line DU 145: evidence for
an autocrine-inhibitory LHRH loop. Cancer Res. 54:4091–4095.
1994.PubMed/NCBI
|
|
33
|
Kéri G, Balogh A, Szöke B, Teplán I and
Csuka O: Gonadotropin-releasing hormone analogues inhibit cell
proliferation and activate signal transduction pathways in
MDA-MB-231 human breast cancer cell line. Tumour Biol. 12:61–67.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gründker C, Günthert AR, Westphalen S and
Emons G: Biology of the gonadotropin-releasing hormone system in
gynecological cancers. Eur J Endocrinol. 146:1–14. 2002. View Article : Google Scholar
|
|
35
|
Moretti RM, Mai S, Montagnani Marelli M,
Bani MR, Ghilardi C, Giavazzi R, Taylor DM, Martini PG and Limonta
P: Dual targeting of tumor and endothelial cells by
gonadotropin-releasing hormone agonists to reduce melanoma
angiogenesis. Endocrinology. 151:4643–4653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taratula O, Garbuzenko OB, Chen AM and
Minko T: Innovative strategy for treatment of lung cancer: targeted
nanotechnology-based inhalation co-delivery of anticancer drugs and
siRNA. J Drug Target. 19:900–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maudsley S, Davidson L, Pawson AJ, Chan R,
López de Maturana R and Millar RP: Gonadotropin-releasing hormone
(GnRH) antagonists promote proapoptotic signaling in peripheral
reproductive tumor cells by activating a Galphai-coupling state of
the type I GnRH receptor. Cancer Res. 64:7533–7544. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Malik SN, Brattain M, Ghosh PM, Troyer DA,
Prihoda T, Bedolla R and Kreisberg JI: Immunohistochemical
demonstration of phospho-Akt in high Gleason grade prostate cancer.
Clin Cancer Res. 8:1168–1171. 2002.PubMed/NCBI
|
|
39
|
Kraus S, Naor Z and Seger R:
Gonadotropin-releasing hormone in apoptosis of prostate cancer
cells. Cancer Lett. 234:109–123. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Günthert AR, Gründker C, Hollmann K and
Emons G: Luteinizing hormone-releasing hormone induces JunD-DNA
binding and extends cell cycle in human ovarian cancer cells.
Biochem Biophys Res Commun. 294:11–15. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song W, Ma Y, Wang J, Brantley-Sieders D
and Chen J: JNK signaling mediates EPHA2-dependent tumor cell
proliferation, motility, and cancer stem cell-like properties in
non-small cell lung cancer. Cancer Res. 74:2444–2454. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yoon CH, Kim MJ, Kim RK, Lim EJ, Choi KS,
An S, Hwang SG, Kang SG, Suh Y, Park MJ, et al: c-Jun N-terminal
kinase has a pivotal role in the maintenance of self-renewal and
tumorigenicity in glioma stem-like cells. Oncogene. 31:4655–4666.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Seino M, Okada M, Shibuya K, Seino S,
Suzuki S, Ohta T, Kurachi H and Kitanaka C: Requirement of JNK
signaling for self-renewal and tumor-initiating capacity of ovarian
cancer stem cells. Anticancer Res. 34:4723–4731. 2014.PubMed/NCBI
|
